Literature DB >> 27402683

The effect of acute ophiobolin A treatment on HO-mediated inflammatory processes.

Anikó Pósa1, Renáta Szabó1, Zita Szalai1, Krisztina Kupai1, Zoltán Deim1, Zsolt Murlasits2, Ottó Bencsik3, András Szekeres3, Csaba Vágvölgyi3, László Balogh4, Béla Juhász5, Zoltán Szilvássy5, Csaba Varga1.   

Abstract

Many microbial and plant-derived metabolites contribute to the production of inflammatory mediators and the expression of pro-inflammatory molecules. Ophiobolin A (OPA) is a fungal secondary metabolite produced by Bipolaris species. The aim of our study was to examine the acute effects of this compound on inflammatory processes. Male Wistar rats were treated with 5% ethanol, 0.01 mg/kg OPA, 0.1 mg/kg OPA and 1.0 mg/kg OPA per os. After 24 h of the administrations, inflammatory mediators such as interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α) and myeloperoxidase (MPO) enzyme as well as heme oxygenase (HO) activity were measured in both plasma and cardiac tissue, along with serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST). We found that OPA caused a significant elevation in the concentrations of IL-6 and TNF-α, increased MPO activity and decreased HO enzyme activity in the plasma. While OPA induces inflammation in the plasma, it did not change the level of inflammatory mediators in the cardiac tissue and the concentrations of serum ALT and AST. Our findings indicate that rapid release of inflammatory mediators by OPA promotes systemic inflammation. However, this acute OPA treatment does not show toxic effects on the cardiac tissue and the concentrations of liver enzymes.

Entities:  

Keywords:  Ophiobolin A (OPA); heme oxygenase; inflammation; myeloperoxidase; pro-inflammatory cytokines

Mesh:

Substances:

Year:  2016        PMID: 27402683     DOI: 10.1177/0960327116658107

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  4 in total

1.  Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A.

Authors:  Keighley N Reisenauer; Yongfeng Tao; Provas Das; Shuxuan Song; Haleigh Svatek; Saawan D Patel; Sheridan Mikhail; Alec Ingros; Peter Sheesley; Marco Masi; Angela Boari; Antonio Evidente; Alexander Kornienko; Daniel Romo; Joseph Taube
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.379

Review 2.  The Biological Activities of Sesterterpenoid-Type Ophiobolins.

Authors:  Wei Tian; Zixin Deng; Kui Hong
Journal:  Mar Drugs       Date:  2017-07-18       Impact factor: 5.118

3.  Screening Mold Colonies by Using Two Toxicity Assays Revealed Indoor Strains of Aspergillus calidoustus Producing Ophiobolins G and K.

Authors:  Marja Johanna Salo; Tamás Marik; Ottó Bencsik; Raimo Mikkola; László Kredics; András Szekeres; Maria A Andersson; Heidi Salonen; Jarek Kurnitski
Journal:  Toxins (Basel)       Date:  2019-11-21       Impact factor: 4.546

4.  New Ophiobolins from the Deep-Sea Derived Fungus Aspergillus sp. WHU0154 and Their Anti-Inflammatory Effects.

Authors:  Wenjuan Ding; Chokkalingam Uvarani; Fangfang Wang; Yaxin Xue; Ning Wu; Liming He; Danmei Tian; Mei Chen; Youwei Zhang; Kui Hong; Jinshan Tang
Journal:  Mar Drugs       Date:  2020-11-20       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.